Scientists think those cholesterol-lowering statins might be doing something else we didn't know about: protecting our brains ...
On-treatment PSA and disease burden should be considered together for prognostication. Achieving PSA ≤0.2 ng/mL within 6–12 weeks strongly predicts favorable long-term survival. Metastatic volume and ...
Among ICU patients with cirrhosis and sepsis, a high lactate-to-hematocrit ratio predicted short- and long-term mortality.